Pacelli, A Former Executive of Dexcom, Inc., Will Lead Epitel Into Its Next Phase of Growth

FDA-Cleared REMI Platform to Begin Initial Commercialization to Hospitals for Use in Emergency Departments and Intensive Care Units Across the United States

Epitel’s second publication has been accepted for publication in a special edition of Frontiers Neurology.